Rick McElheny
Corporate Officer/Principal bei CLEARSIDE BIOMEDICAL, INC.
Profil
Rick McElheny is the founder of Vidara Therapeutics Holdings LLC.
He is currently the Vice President of Business Development at Clearside Biomedical, Inc. He was previously the Vice President of Development & Supply at HZNP USA LLC from 2011 to 2015 and the Director of Corporate Development at Meda Pharmaceuticals, Inc. He holds an MBA from New York University and an undergraduate degree from The Pennsylvania State University.
Aktive Positionen von Rick McElheny
Unternehmen | Position | Beginn |
---|---|---|
CLEARSIDE BIOMEDICAL, INC. | Corporate Officer/Principal | 08.11.2016 |
Ehemalige bekannte Positionen von Rick McElheny
Unternehmen | Position | Ende |
---|---|---|
HZNP USA LLC
HZNP USA LLC Pharmaceuticals: MajorHealth Technology HZNP USA LLC acquires, develops, markets and distributes specialty pharmaceutical products. The firm offers Actimmune, which is a bioengineered form of interferon gamma-1b, a protein that acts as a biologic response modifier through stimulation of the human immune system. Its Actimmune product is used for reducing the frequency and severity of serious infections related to chronic granulomatous diseases, and for delaying time to disease progression in patients with severe malignant osteopetrosis. The company was founded in 2011 by Balaji K. Venkataraman and Virinder Nohria and is headquartered in Lake Forest, FL. | Corporate Officer/Principal | 01.01.2015 |
Meda Pharmaceuticals, Inc.
Meda Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Meda Pharmaceuticals, Inc. manufactures and develops drugs and pharmaceuticals. The firm specializes in respiratory, allergy, central nervous system, and cough-cold products. Its products include Aerospan, Anadrol-50, Astelin, Astepro, BiferaRx, Butisol Sodium, Cesame, Colyte, Cortifoam, Demadex, Depen, Dipentum, Edlua, Rowasa, Optivar, Soma and Levsin. The company was founded in 2001 and is headquartered in Somerset, NJ. | Corporate Officer/Principal | 01.01.2011 |
Vidara Therapeutics Holdings LLC | Gründer | - |
Ausbildung von Rick McElheny
New York University | Masters Business Admin |
The Pennsylvania State University | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
CLEARSIDE BIOMEDICAL, INC. | Health Technology |
Private Unternehmen | 3 |
---|---|
Meda Pharmaceuticals, Inc.
Meda Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Meda Pharmaceuticals, Inc. manufactures and develops drugs and pharmaceuticals. The firm specializes in respiratory, allergy, central nervous system, and cough-cold products. Its products include Aerospan, Anadrol-50, Astelin, Astepro, BiferaRx, Butisol Sodium, Cesame, Colyte, Cortifoam, Demadex, Depen, Dipentum, Edlua, Rowasa, Optivar, Soma and Levsin. The company was founded in 2001 and is headquartered in Somerset, NJ. | Health Technology |
Vidara Therapeutics Holdings LLC | Miscellaneous |
HZNP USA LLC
HZNP USA LLC Pharmaceuticals: MajorHealth Technology HZNP USA LLC acquires, develops, markets and distributes specialty pharmaceutical products. The firm offers Actimmune, which is a bioengineered form of interferon gamma-1b, a protein that acts as a biologic response modifier through stimulation of the human immune system. Its Actimmune product is used for reducing the frequency and severity of serious infections related to chronic granulomatous diseases, and for delaying time to disease progression in patients with severe malignant osteopetrosis. The company was founded in 2011 by Balaji K. Venkataraman and Virinder Nohria and is headquartered in Lake Forest, FL. | Health Technology |